1. Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin). Issue 4 (25th November 2008) Authors: Georgopoulos, M; Polak, K; Prager, F; Prünte, C; Schmidt-Erfurth, U Journal: British journal of ophthalmology Issue: Volume 93:Issue 4(2009) Page Start: 457 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Issue 4 (22nd January 2008) Authors: Kriechbaum, K; Michels, S; Prager, F; Georgopoulos, M; Funk, M; Geitzenauer, W; Schmidt-Erfurth, U Journal: British journal of ophthalmology Issue: Volume 92:Issue 4(2008) Page Start: 518 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study. Issue 3 (26th February 2008) Authors: Weigert, G; Michels, S; Sacu, S; Varga, A; Prager, F; Geitzenauer, W; Schmidt-Erfurth, U Journal: British journal of ophthalmology Issue: Volume 92:Issue 3(2008) Page Start: 356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Intravitreal bevacizumab (Avastin®) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Issue 4 (15th December 2008) Authors: Prager, F; Michels, S; Kriechbaum, K; Georgopoulos, M; Funk, M; Geitzenauer, W; Polak, K; Schmidt-Erfurth, U Journal: British journal of ophthalmology Issue: Volume 93:Issue 4(2009) Page Start: 452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗